Medical Pike NewsPSA Rising
  HOME LATEST: ARCHIVE : PAIN CONTROL








Sources, Links, Related Stories
outside sites
open in fresh window

Actiq, New Drug for Breathrough Pain

JNCI article abstract Apr 98


Pain Management
Resources


Bone Cancer Pain
Clinical Trial of New Therapy
Feb 99


Electrical Nerve Stimulation May Ease BoneCancer Pain


Cancer Pain Widespread,
Often Untreated

One in four elderly cancer patients
gets no medication for pain

April 3, 1999 Last year a five-state study showed that daily pain among nursing home residents with cancer is widespread and often untreated, especially among older and minority patients. Appearing in the June 17 1998 Journal of the American Medical Association, the study found that many frail and older cancer patients receive inadequate medical treatment and that dramatic room exists for improving how pain is managed in these individuals.
     Among those affected by inadequate pain care in nursing homes are patients who have advanced prostate cancer. Typically, the disease spreads to the bones. It may cause flares of the extreme "breakthrough" pain, which the new drug Actiq is designed to treat. Almost forty thousand men a year die of prostate cancer. Knowing that it kills some men in their forties and fifties, activists are fighting the stereotype of prostate cancer as a disease of old men. Nonethless (as with breast, lung, and colon cancer) the majority of patients are over 65. Many are in nursing homes or VA hospitals.
     These men are among patients who might benefit from Actiq -- but only patients who are already on medication for around-the-clock pain can use Actiq. The drug is specifically designed for patients who are "already receiving, and tolerant to, opioid therapy for their underlying, persistent cancer pain."
     What of those who aren't getting even minimal care? Last year, Giovanni Gambassi, M.D., visiting professor in the Center for Gerontology and Health Care Research at Brown University, found that 1 out of 4 cancer patients in nursing homes who said they had cancer pain never received any medication at all.
More Elderly Patients, Less Pain Care
     "We're not pointing fingers, but we know that nursing homes and many clinical settings do not do a good job in this area, and here's more proof," Dr. Gambassi said.
     "At some point, nursing home staff and in-house doctors may give up on patients who they know are going to die," he said. "The results of our study are particularly alarming since there are ways to treat patients to greatly relieve their conditions. There is no acceptable excuse for not treating pain appropriately in terminally ill patients."
    
Gambassi and colleagues examined data collected on 13,625 cancer patients aged 65 and older discharged from hospitals to 1,492 nursing homes from 1992 to 1995. "In total, 4,003 patients reported daily pain. Of those, 16 percent received a simple analgesic such as aspirin or acetaminophen. Thirty-two percent were given codeine or other weak opioids, and 26 percent received morphine."
      "However, 26 percent of patients with daily pain received no analgesics, not even an aspirin or acetaminophen tablet," the authors found. "Patients older than 85 years in daily pain were about 50 percent less likely to receive any analgesic than those aged 65 to 74 years. Only 13 percent of patients aged 85 years and older received codeine or other weak opiates or morphine, compared to 38 percent of those aged 65 to 74 years."
     "Failure to prevent or to treat pain effectively is unacceptable and should be considered a first-line indicator of poor quality of medical care," Dr. Gambassi said. He and his team called for solutions that address barriers to pain management including the unwillingness of many nursing homes to handle opiates, inadequate staff to provide and monitor adequate use of painkillers, and reluctance or inability of some patients -- especially the elderly and patients who don't speak fluent English -- to demand proper pain medication.
     African Americans were fifty percent less likely than whites to receive any analgesics. Although not statistically significant, a similar trend in the data was noted for Hispanics, Asians and American Indians. For minority patients, the authors suggest that language barriers account for some of the differences.
     Cultural and language backgrounds affect ratings of how pain interferes with physical function, mood and sleep. There is evidence that Hispanics are more reluctant to report pain and, like African Americans, less willing to complete advanced directives.

     Only recently have medical schools offered training on the care of terminally ill elderly, Gambassi said. There still is a need to educate individual clinicians and patients to influence their behaviors, he said. "We must tear down the cultural, social and intellectual barriers to do a better job of attending to those who are terminally ill."
How This Study Was Done
The study came up with a one-time "snapshot" of cancer pain management. The information came from the Systematic Assessment of Geriatric Drug Use via Epidemiology (SAGE) database, established and maintained by Brown University. The data was collected as part of the Health Care Financing Administration's Multistate Nursing Home Case-mix and Quality Demonstration Project.
     Nursing home staff in all Medicare and Medicaid facilities in Kansas, Maine, Mississippi, New York and South Dakota evaluated patients using a 350-item data set. In addition, nursing staff recorded up to 18 different medications received by each resident in the prior seven days.
     The SAGE group grew out of collaborative effort between faculty at Brown and at Catholic University in Rome.
Cover
Upfront
Voices
Eatingwell
Grassroots Advocacy
Pages of links
Cover
Email us!To contact us or report problems with pages E-mail
[email protected]
April 3, 1999
to top
PSA Rising
prostate cancer survivor news
http://www.psa-rising.com ©2000